A meta-analysis of cyclosporine treatment for Stevens–Johnson syndrome/toxic epidermal necrolysis

QR Code

A meta-analysis of cyclosporine treatment for Stevens–Johnson syndrome/toxic epidermal necrolysis

Qin Xiang Ng,1,2 Michelle Lee Zhi Qing De Deyn,3 Nandini Venkatanarayanan,4 Collin Yih Xian Ho,2 Wee-Song Yeo,5 1Department of Medicine, National University Hospital, National University Health System, Singapore; 2MOH Holdings Pte Ltd, Singapore; 3Department of Medicine, James Cook University Hospit...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ng QX, De Deyn MLZQ, Venkatanarayanan N, Ho CYX, Yeo WS
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	SJS TEN epidermal necrolysis cyclosporine CsA meta-analysis Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/307d3c095de646f7b9fef75e9c5998f3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): an update
par: O. Mogole, et autres
Publié: (2016)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
par: Mayumi Ueta
Publié: (2021)

Clinical Case of Toxic Epidermal Necrolysis
par: Radenkova-Saeva J., et autres
Publié: (2017)

Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications
par: Mayumi Ueta
Publié: (2021)

Uso de inmunoglobulina humana endovenosa en pacientes con necrolisis epidérmica tóxica y síndrome de sobreposición Stevens Johnson necrolisis tóxica epidérmica
par: Molgó,Montserrat, et autres
Publié: (2009)

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications
par: Mayumi Ueta, et autres
Publié: (2021)

Stability, safety, and transcorneal mechanistic studies of ophthalmic lyophilized cyclosporine-loaded polymeric micelles
par: Shen Y, et autres
Publié: (2018)

Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents
par: Karol Skłodowski, et autres
Publié: (2021)

Remission of Kimura Disease With Carotid Hypervascularization After Cyclosporine Treatment
par: Severino Persechino, et autres
Publié: (2020)

Effect of Erythromycin on the Intestinal Transport of Cyclosporine
par: P Zakeri Milani,, et autres
Publié: (2009)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
par: Deveney T, et autres
Publié: (2018)

Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
par: Awara A, et autres
Publié: (2020)

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
par: Periman LM, et autres
Publié: (2020)

Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies
par: Li Y, et autres
Publié: (2020)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
par: de Oliveira RC, et autres
Publié: (2019)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
par: Rhee MK, et autres
Publié: (2017)

Cyclosporine A micellar delivery system for dry eyes
par: Kang H, et autres
Publié: (2016)

Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
par: AVILA,ANA D, et autres
Publié: (2007)

Cyclosporine Biosynthesis in <italic toggle="yes">Tolypocladium inflatum</italic> Benefits Fungal Adaptation to the Environment
par: Xiuqing Yang, et autres
Publié: (2018)

Study of foliar epidermal anatomy of four pistachio rootstocks under water stress
par: Arzani,Kazem, et autres
Publié: (2013)

Topical Cyclosporine in Oral Lichen Planus—A Series of 21 Open-Label, Biphasic, Single-Patient Observations
par: Babak Monshi, et autres
Publié: (2021)

Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
par: Katsuyama A, et autres
Publié: (2019)

A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca
par: Jerkins GW, et autres
Publié: (2020)

COMPARATIVE FOLIAR EPIDERMAL MORPHOLOGY OF THE WEST AFRICAN SPECIES OF THE GENUS AFZELIA SMITH (LEGUMINOSAE: AESALPINIOIDEAE)
par: Babalola Kadiri,Akeem, et autres
Publié: (2008)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
par: Burade V, et autres
Publié: (2020)

Epidermal Cyst on the Face of a Child, Clinically and Dermoscopically Mimicking Pilomatricoma
par: Jelena Krtanjek, et autres
Publié: (2019)

Febrile Ulceronecrotic Mucha-Habermann Disease: A Rare Case Report and Review of Cases Treated With Oral Cyclosporine
par: Apasee Sooksamran, et autres
Publié: (2021)

A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers
par: Karpecki PM, et autres
Publié: (2019)

Cyclosporine A Induces Cardiac Developmental Toxicity in Zebrafish by Up-Regulation of Wnt Signaling and Oxidative Stress
par: Mengqi Wan, et autres
Publié: (2021)

Dermoscopy of Epidermization of Lip Indicating Focal Compact Sebaceous Metaplasia
par: Shailesh Malani, et autres
Publié: (2021)

Assessment of molecular recognition element for the quantification of human epidermal growth factor using surface plasmon resonance
par: Rosti,Ira Amira, et autres
Publié: (2013)

Cyclosporin A-treated Dendritic Cells may affect the outcome of organ transplantation by decreasing CD4+CD25+ regulatory T cell proliferation
par: Pino-Lagos,Karina, et autres
Publié: (2010)

Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy
par: Nebbioso M, et autres
Publié: (2019)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
par: White DE, et autres
Publié: (2019)

Epidermal Hyaluronan in Barrier Alteration-Related Disease
par: Céline Evrard, et autres
Publié: (2021)

Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
par: Matossian C, et autres
Publié: (2021)

Comparison Shopping Agents and Online Price Dispersion: A Search Cost based Explanation
par: Pathak,Bhavik K
Publié: (2012)

Stevens‐Johnson Syndrome due to COVID‐19 vaccination
par: Parvin Mansouri, et autres
Publié: (2021)

Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
par: Hovanesian JA, et autres
Publié: (2021)

A Pediatric Case of Papular Epidermal Nevus With “Skyline” Basal Cell Layer (PENS)
par: Federico E. Strambach, et autres
Publié: (2019)